TrialAnnals of the rheumatic diseases2015

Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study.

A Kavanaugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.